Literature DB >> 2999605

A role for Ni in the hormonal stimulation of adenylate cyclase.

R A Cerione, C Staniszewski, M G Caron, R J Lefkowitz, J Codina, L Birnbaumer.   

Abstract

The best understood system for transduction of extracellular messages into intracellular signals is the hormone receptor-coupled adenylate cyclase. In such systems receptors are functionally coupled to the enzyme by two special proteins, termed the stimulatory and inhibitory guanine nucleotide regulatory proteins (Ns and Ni, respectively). These proteins, thought to mediate, respectively, stimulatory and inhibitory influences on the adenylate cyclase, are members of a larger class of heterotrimeric guanine nucleotide regulatory proteins involved in membrane signal transduction. We have studied the interactions of the various components of the adenylate cyclase system by co-reconstituting pure beta-adrenergic receptors, pure Ns and Ni, and functionally resolved preparations of the catalyst in phospholipid vesicles. In the absence of Ni, beta-adrenergic receptor/Ns-mediated catecholamine stimulation of the enzyme is relatively modest (approximately 1.3-fold). Surprisingly, however, when Ni is also present, stimulation increases dramatically (up to 7-8-fold) because of a greater suppression of basal relative to agonist-stimulated enzyme activity. Thus, Ni may actually be required for maximal agonist stimulation as well as for inhibition of the adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999605     DOI: 10.1038/318293a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Activation of adenylate cyclase in human platelet membranes by guanosine 5'-[beta gamma-imido]triphosphate is inhibited by cyclic-AMP-dependent phosphorylation. Slow activation occurs in the absence of ATP.

Authors:  R W Farndale; S K Wong; B R Martin
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

Review 2.  Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins.

Authors:  G Milligan
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

Review 3.  [Guanidine nucleotide binding proteins as membrane signal transduction components and regulators of enzymatic effectors].

Authors:  W Rosenthal; G Schultz
Journal:  Klin Wochenschr       Date:  1988-06-15

4.  The beta-adrenoceptor-adenylate cyclase complex. From model to biochemical reality.

Authors:  A P Ijzerman; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1986-08-22

5.  Impaired cardiac muscarinic receptor function in dogs with heart failure.

Authors:  D E Vatner; D L Lee; K R Schwarz; J P Longabaugh; A M Fujii; S F Vatner; C J Homcy
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Differential regulation of amounts of the guanine-nucleotide-binding proteins Gi and Go in neuroblastoma x glioma hybrid cells in response to dibutyryl cyclic AMP.

Authors:  I Mullaney; A I Magee; C G Unson; G Milligan
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

7.  Characterization of the G protein coupling of a glucagon receptor to the KATP channel in insulin-secreting cells.

Authors:  B Ribalet; S Ciani
Journal:  J Membr Biol       Date:  1994-12       Impact factor: 1.843

8.  Supra-additive activation of guinea-pig superior cervical ganglion adenylate cyclase by PGE2 and D-Ala2-Met-enkephalinamide: role of GTP.

Authors:  C Biondi; P G Borasio; M E Ferretti; M C Pareschi
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

9.  Differential regulation of G-protein expression by vasoactive peptides.

Authors:  M B Anand-Srivastava; A Palaparti; J Pion
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

10.  Pertussis toxin prevents the inhibitory effect of adenosine and unmasks adenosine-induced excitation of mammalian motor nerve endings.

Authors:  E M Silinsky; C Solsona; J K Hirsh
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.